Pharmaceuticals News and Research

RSS

Drug Discovery and Development to focus on pharmaceutical trends

NanoViricides, Inc., announced today that the Company’s CEO, Eugene Seymour, MD, MPH has been invited as a panelist at the 2nd Annual Livingston Healthcare Summit on September 24th, 2009 in New York City.

24 Sep 2009

Spherix's Annual Meeting of Shareholders to be held on November 17

Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Annual Meeting of Shareholders will be held on November 17, 2009, at 9:00 a.m. Eastern time, at the Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, Maryland 20817.

24 Sep 2009

Patents listed in FDA's Orange Book for Eli Lilly’s Evista invalidated

Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA’s Orange Book for Eli Lilly’s Evista® (raloxifene hydrochloride) Tablets in litigation concerning Teva’s abbreviated new drug application to market a generic version. The court found these patents to be invalid for lack of written description.

24 Sep 2009

Pfizer earns highest score in the 2010 Corporate Equality Index

Pfizer Inc today announced that it has earned a score of 100 — the highest possible — in the 2010 Corporate Equality Index, which evaluates U.S.-based businesses on their treatment of lesbian, gay, bisexual and transgender (LGBT) employees, investors and consumers.

24 Sep 2009

Restrictive policies in India discourages medical and pharmaceutical innovation: USIBC report

At a roundtable organized by the Coalition for Innovation Employment and Development, the U.S.-India Business Council's 'Coalition for Healthy India' released the findings of its report on "The Value of Incremental Pharmaceutical Innovation: Benefits for Indian Patients and Indian Business". The report highlights and substantiates the impact of restrictive policies in India, with respect to medical and pharmaceutical innovation.

24 Sep 2009

Sinobiopharma reports an increase of 112.69 percent in sales revenue for the fiscal year ended May 31, 2009

Sinobiopharma, Inc. ("Sinobiopharma" or the "Company") is pleased to report financial highlights from the audited financial results for the fiscal year ended May 31, 2009.

24 Sep 2009

HPV screening and vaccination programmes could eradicate cervical cancer

Cervical cancer could be eradicated within the next 50 years if countries implement national screening programmes based on detection of the human papilloma virus (HPV), which causes the disease, together with vaccination programmes against the virus, according to a cervical cancer screening expert.

24 Sep 2009

Max Neeman International partners with Max Healthcare to open a Phase I/IIa clinical trial unit

Max Neeman International, a leading Indian CRO, announced a partnership with Max Healthcare to open a Phase I/IIa clinical trial unit at Max Super Speciality Hospital, New Delhi, India. This proof of concept unit will allow Pharmaceutical, Biotech & Device companies the option to complete a critical part of the development process across multiple therapeutic areas quickly and with the highest quality.

24 Sep 2009

Octapharma AG submits Biological License Application for its octagam(R) 10% to FDA

Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration (FDA) with the goal of expanding the biopharmaceutical company's U.S. immune globulin therapy portfolio by early 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic Purpura (ITP), a blood-clotting disorder that can result in excessive bruising and bleeding.

24 Sep 2009

PCMA releases statement regarding the Senate Finance Committee’s ongoing deliberations on health-care reform

“As the Senate Finance Committee continues to craft legislation, the next 48 hours will be critical in determining whether health reform delivers on the promise of making prescription drugs more affordable for all Americans. With nearly $245 billion spent annually on prescription drugs, Americans want the peace of mind that comes from knowing that reform makes common-sense improvements that lower the cost of prescriptions for everyone.

24 Sep 2009

Collaborative clinical care network at Cincinnati Children's Hospital Medical Center

Fostering innovation to speed the improvement of health care is the goal of an $8.3 million grant to researchers at Cincinnati Children's Hospital Medical Center.

24 Sep 2009

Merck, QIAGEN to collaborate to increase access to HPV vaccination and HPV DNA testing in developing countries

Merck & Co., Inc. and QIAGEN N.V. today announced their intent to collaborate on a new program to increase access to HPV vaccination and HPV DNA testing in some of the most resource-poor areas of the world.

From QIAGEN Manchester Limited 24 Sep 2009

Clinical study results of Novolimus and Myolimum eluting coronary stent systems released

Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today positive results from three multicenter first-in-man studies of Novolimus and Myolimus eluting coronary stent systems with durable and bioabsorbable polymers. Findings were presented at the 21st Annual Transcatheter Cardiovascular Therapeutics (TCT 2009) scientific symposium.

24 Sep 2009

Republicans criticize Democrat's direction, Finance Committee timing

Just as Senate Finance Committee action is heating up, tempers on both sides of the aisle are flaring, as senators stake out positions and weigh political implications of their positions.

24 Sep 2009

New version of Adis R&D Insight global pipeline database launched

Wolters Kluwer Pharma Solutions, Inc., a leading provider of market data and competitive intelligence to the pharmaceutical and biotech industries, today introduced a powerful, new version of its popular Adis R&D Insight global pipeline database.

24 Sep 2009

ThromboGenics completes enrollment for MIVI-TRUST clinical trial

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that it has completed the enrolment of the US Phase III trial evaluating microplasmin for the non-surgical treatment of eye disease.

24 Sep 2009

Rasagiline slows the rate of Parkinson's disease progression

Following one of the largest studies ever conducted in Parkinson's disease (PD), researchers at Mount Sinai School of Medicine report today in The New England Journal of Medicine that rasagiline, a drug currently used to treat the symptoms of PD, may also slow the rate of disease progression.

24 Sep 2009

Clinical Site Services launches new website providing clinical trial information

Clinical Site Services (CSS), a leader in patient enrollment solutions for the clinical research industry, announces the launch of its comprehensive website,http://www.MyClinicalTrial.com, which is focused on advancing the significance of clinical research.

24 Sep 2009

Court rules in favor of Eli Lilly for Evista's method-of-use patents

The U.S. District Court for the Southern District of Indiana today upheld Eli Lilly and Company's (NYSE: LLY) method-of-use patents on Evista(R) (raloxifene HCl tablets). In the case of Eli Lilly and Company v. Teva Pharmaceuticals Industries Ltd., the court ruled in favor of Lilly on all accounts for these method-of-use patents, including the patent doctrines of obviousness, enablement, and inequitable conduct.

24 Sep 2009

States extend, create new programs for vulnerable; In Texas, home health a problem

New outlets report on a variety of health stories at the state level including a new program that provides prescription drug help and routine medical care to low-income people in Iowa, an assurance that poor children will be able to keep their insurance in California and recognition that home health agencies waste Medicare dollars in Texas.

24 Sep 2009

Pharmaceuticals News and Research

Drug Discovery and Development to focus on pharmaceutical trends

Spherix's Annual Meeting of Shareholders to be held on November 17

Patents listed in FDA's Orange Book for Eli Lilly’s Evista invalidated

Pfizer earns highest score in the 2010 Corporate Equality Index

Restrictive policies in India discourages medical and pharmaceutical innovation: USIBC report

Sinobiopharma reports an increase of 112.69 percent in sales revenue for the fiscal year ended May 31, 2009

HPV screening and vaccination programmes could eradicate cervical cancer

Max Neeman International partners with Max Healthcare to open a Phase I/IIa clinical trial unit

Octapharma AG submits Biological License Application for its octagam(R) 10% to FDA

PCMA releases statement regarding the Senate Finance Committee’s ongoing deliberations on health-care reform

Collaborative clinical care network at Cincinnati Children's Hospital Medical Center

Merck, QIAGEN to collaborate to increase access to HPV vaccination and HPV DNA testing in developing countries

Clinical study results of Novolimus and Myolimum eluting coronary stent systems released

Republicans criticize Democrat's direction, Finance Committee timing

New version of Adis R&D Insight global pipeline database launched

ThromboGenics completes enrollment for MIVI-TRUST clinical trial

Rasagiline slows the rate of Parkinson's disease progression

Clinical Site Services launches new website providing clinical trial information

Court rules in favor of Eli Lilly for Evista's method-of-use patents

States extend, create new programs for vulnerable; In Texas, home health a problem

Pittcon Highlights: Pharmaceutical & Biologic eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring